Moderna’s Patent Settlement Clears Path ForwardBusiness PenMarch 4, 2026 March 4, 2026 Moderna, Inc. (NASDAQ: MRNA) has built its name on messenger RNA, or mRNA, technology. This approach instructs cells to produce proteins that trigger immune responses....
